Next-generation sequencing (NGS) as a diagnostic tool for retinal degeneration reveals a much higher detection rate in early-onset disease.

Shanks, M; Downes, S; Copley, R; Lise, S; Broxholme, J; Hudspith, K; Kwasniewska, A; Davies, W; Hankins, M; Packham, E; Clouston, P; Seller, A; Wilkie, A; Taylor, J; Ragoussis, J; Németh, A

Journal article

Next-generation sequencing (NGS) as a diagnostic tool for retinal degeneration reveals a much higher detection rate in early-onset disease.

Abstract:: Inherited retinal degeneration (IRD) is a common cause of visual impairment (prevalence ∼1/3500). There is considerable phenotype and genotype heterogeneity, making a specific diagnosis very difficult without molecular testing. We investigated targeted capture combined with next-generation sequencing using Nimblegen 12plex arrays and the Roche 454 sequencing platform to explore its potential for clinical diagnostics in two common types of IRD, retinitis pigmentosa and cone-rod dystrophy. 50 patients (36 unknowns and 14 positive controls) were screened, and pathogenic mutations were identified in 25% of patients in the unknown, with 53% in the early-onset cases. All patients with new mutations detected had an age of onset <21 years and 44% had a family history. Thirty-one percent of mutations detected were novel. A de novo mutation in rhodopsin was identified in one early-onset case without a family history. Bioinformatic pipelines were developed to identify likely pathogenic mutations and stringent criteria were used for assignment of pathogenicity. Analysis of sequencing metrics revealed significant variability in capture efficiency and depth of coverage. We conclude that targeted capture and next-generation sequencing are likely to be very useful in a diagnostic setting, but patients with earlier onset of disease are more likely to benefit from using this strategy. The mutation-detection rate suggests that many patients are likely to have mutations in novel genes.

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Shanks, M., Downes, S., Copley, R., Lise, S., Broxholme, J., Hudspith, K., Kwasniewska, A., Davies, W., Hankins, M., Packham, E., Clouston, P., Seller, A., Wilkie, A., Taylor, J., Ragoussis, J., & Németh, A. (2013). Next-generation sequencing (NGS) as a diagnostic tool for retinal degeneration reveals a much higher detection rate in early-onset disease. European Journal of Human Genetics : EJHG, 21(3), 274–280.

MLA Style

Shanks, M, et al. “Next-Generation Sequencing (NGS) as a Diagnostic Tool for Retinal Degeneration Reveals a Much Higher Detection Rate in Early-Onset Disease.” European Journal of Human Genetics : EJHG, vol. 21, no. 3, 2013, pp. 274–80.

Chicago Style

Shanks, M, S Downes, R Copley, et al. 2013. “Next-Generation Sequencing (NGS) as a Diagnostic Tool for Retinal Degeneration Reveals a Much Higher Detection Rate in Early-Onset Disease.” European Journal of Human Genetics : EJHG 21 (3): 274–80.
Print